Erratum to "IL-10 production by B cells is differentially regulated by immune-mediated and infectious stimuli and requires p38 activation" [Mol. Immunol. 62 (2014) 266-276] DOI: 10.1016/j.molimm.2014.05.018;IL-10 production by B cells is differentially regulated by immune-mediated and infectious stimuli and requires p38 activation

Molecular Immunology

Volumn 62, Issue 2, 2014, Pages 266-276

  Mion, Francesca ^a   Tonon, Silvia ^a   Toffoletto, Barbara ^a   Cesselli, Daniela ^a   Pucillo, Carlo E ^a   Vitale, Gaetano ^a  

^a UNIVERSITY OF UDINE   (Italy)

Author keywords

B cells; CD40; IL 10; MyD88; P38; TLR

Indexed keywords

1,4 DIAMINO 1,4 BIS(2 AMINOPHENYLTHIO) 2,3 DICYANOBUTADIENE; 2 (2 AMINO 3 METHOXYPHENYL)CHROMONE; 4 (4 FLUOROPHENYL) 2 (4 METHYLSULFINYLPHENYL) 5 (4 PYRIDYL)IMIDAZOLE; ANTHRA[1,9 CD]PYRAZOL 6(2H) ONE; B CELL ACTIVATING FACTOR; CD40 LIGAND MONOCLONAL ANTIBODY; INTERLEUKIN 10; LIPOPOLYSACCHARIDE; MITOGEN ACTIVATED PROTEIN KINASE; SYNAPTOPHYSIN; TOLL LIKE RECEPTOR AGONIST; VX 702; IL10 PROTEIN, MOUSE; IMMUNOLOGIC FACTOR; MITOGEN ACTIVATED PROTEIN KINASE P38; MYELOID DIFFERENTIATION FACTOR 88;

B LYMPHOCYTE; CELL DIFFERENTIATION; CELL MATURATION; COMPARATIVE STUDY; CYTOKINE PRODUCTION; CYTOKINE RELEASE; ENZYME ACTIVATION; GENE EXPRESSION; NONHUMAN; PHENOTYPE; REVIEW; SIGNAL TRANSDUCTION; ANIMAL; ARTICLE; B CELLS; C57BL MOUSE; CD40; FEMALE; IMMUNOLOGY; P38; TLR;

B CELLS; CD40; IL-10; MYD88; P38; TLR;

ANIMALS; B-LYMPHOCYTES; FEMALE; IMMUNOLOGIC FACTORS; INTERLEUKIN-10; LIPOPOLYSACCHARIDES; MICE, INBRED C57BL; P38 MITOGEN-ACTIVATED PROTEIN KINASES; SIGNAL TRANSDUCTION;

EID: 84908128200     PISSN: 01615890     EISSN: 18729142     Source Type: Journal    
DOI: 10.1016/j.molimm.2014.10.002     Document Type: Erratum

References (35)

1. Barton G.M., Medzhitov R. Toll-like receptor signaling pathways. Science 2003, 300:1524-1525.
2. Bennett B.L., Sasaki D.T., Murray B.W., O'Leary E.C., Sakata S.T., Xu W., Leisten J.C., Motiwala A., Pierce S., Satoh Y., Bhagwat S.S., Manning A.M., Anderson D.W. SP600125, an anthrapyrazolone inhibitor of Jun N-terminal kinase. Proc. Nat. Acad. Sci. U.S.A. 2001, 98:13681-13686.
3. Blair P.A., Norena L.Y., Flores-Borja F., Rawlings D.J., Isenberg D.A., Ehrenstein M.R., Mauri C. CD19(+)CD24(hi)CD38(hi) B cells exhibit regulatory capacity in healthy individuals but are functionally impaired in systemic lupus erythematosus patients. Immunity 2010, 32:129-140.
4. Conti P., Kempuraj D., Kandere K., Di Gioacchino M., Barbacane R.C., Castellani M.L., Felaco M., Boucher W., Letourneau R., Theoharides T.C. IL-10, an inflammatory/inhibitory cytokine, but not always. Immunol. Lett. 2003, 86:123-129.
5. Cuenda A., Rouse J., Doza Y.N., Meier R., Cohen P., Gallagher T.F., Young P.R., Lee J.C. SB 203580 is a specific inhibitor of a MAP kinase homologue which is stimulated by cellular stresses and interleukin-1. FEBS Lett. 1995, 364:229-233.
6. Damjanov N., Kauffman R.S., Spencer-Green G.T. Efficacy, pharmacodynamics, and safety of VX-702, a novel p38 MAPK inhibitor, in rheumatoid arthritis: results of two randomized, double-blind, placebo-controlled clinical studies. Arthritis Rheum. 2009, 60:1232-1241.
7. DiLillo D.J., Matsushita T., Tedder T.F. B10 cells and regulatory B cells balance immune responses during inflammation, autoimmunity, and cancer. Ann. N.Y. Acad. Sci. 2010, 1183:38-57.
8. Dudley D.T., Pang L., Decker S.J., Bridges A.J., Saltiel A.R. A synthetic inhibitor of the mitogen-activated protein kinase cascade. Proc. Nat. Acad. Sci. U.S.A. 1995, 92:7686-7689.
9. Favata M.F., Horiuchi K.Y., Manos E.J., Daulerio A.J., Stradley D.A., Feeser W.S., Van Dyk D.E., Pitts W.J., Earl R.A., Hobbs F., Copeland R.A., Magolda R.L., Scherle P.A., Trzaskos J.M. Identification of a novel inhibitor of mitogen-activated protein kinase kinase. J. Biol. Chem. 1998, 273:18623-18632.
10. Gary-Gouy H., Harriague J., Bismuth G., Platzer C., Schmitt C., Dalloul A.H. Human CD5 promotes B-cell survival through stimulation of autocrine IL-10 production. Blood 2002, 100:4537-4543.
11. Goldstein D.M., Kuglstatter A., Lou Y., Soth M.J. Selective p38alpha inhibitors clinically evaluated for the treatment of chronic inflammatory disorders. J. Med. Chem. 2010, 53:2345-2353.
12. Jabara H.H., Geha R.S. Jun N-terminal kinase is essential for CD40-mediated IgE class switching in B cells. J. Allergy Clin. Immunol. 2005, 115:856-863.
13. Jin G., Hamaguchi Y., Matsushita T., Hasegawa M., Le Huu D., Ishiura N., Naka K., Hirao A., Takehara K., Fujimoto M. B-cell linker protein expression contributes to controlling allergic and autoimmune diseases by mediating IL-10 production in regulatory B cells. J. Allergy Clin. Immunol. 2013, 131:1674-1682.
14. Klinker M.W., Lundy S.K. Multiple mechanisms of immune suppression by B lymphocytes. Mol. Med. 2012, 18:123-137.
15. Lahti A., Jalonen U., Kankaanranta H., Moilanen E. c-Jun NH2-terminal kinase inhibitor anthra(1,9-cd)pyrazol-6(2H)-one reduces inducible nitric-oxide synthase expression by destabilizing mRNA in activated macrophages. Mol. Pharmacol. 2003, 64:308-315.
16. Lampropoulou V., Hoehlig K., Roch T., Neves P., Calderon Gomez E., Sweenie C.H., Hao Y., Freitas A.A., Steinhoff U., Anderton S.M., Fillatreau S. TLR-activated B cells suppress T cell-mediated autoimmunity. J. Immunol. 2008, 180:4763-4773.
17. LeBien T.W., Tedder T.F. B lymphocytes: how they develop and function. Blood 2008, 112:1570-1580.
18. Matsumoto M., Fujii Y., Baba A., Hikida M., Kurosaki T., Baba Y. The calcium sensors STIM1 and STIM2 control B cell regulatory function through interleukin-10 production. Immunity 2011, 34:703-714.
19. Mauri C., Bosma A. Immune regulatory function of B cells. Annu. Rev. Immunol. 2012, 30:221-241.
20. Mauri C., Gray D., Mushtaq N., Londei M. Prevention of arthritis by interleukin 10-producing B cells. J. Exp. Med. 2003, 197:489-501.
21. Merluzzi S., Moretti M., Altamura S., Zwollo P., Sigvardsson M., Vitale G., Pucillo C. CD40 stimulation induces Pax5/BSAP and EBF activation through a APE/Ref-1-dependent redox mechanism. J. Biol. Chem. 2004, 279:1777-1786.
22. Mizoguchi A., Bhan A.K. A case for regulatory B cells. J. Immunol. 2006, 176:705-710.
23. Peng S.L. Signaling in B cells via Toll-like receptors. Curr. Opin. Immunol. 2005, 17:230-236.
24. Piatelli M.J., Doughty C., Chiles T.C. Requirement for a hsp90 chaperone-dependent MEK1/2-ERK pathway for B cell antigen receptor-induced cyclin D2 expression in mature B lymphocytes. J. Biol. Chem. 2002, 277:12144-12150.
25. Rousset F., Garcia E., Defrance T., Peronne C., Vezzio N., Hsu D.H., Kastelein R., Moore K.W., Banchereau J. Interleukin 10 is a potent growth and differentiation factor for activated human B lymphocytes. Proc. Nat. Acad. Sci. U.S.A. 1992, 89:1890-1893.
26. Saraiva M., Christensen J.R., Veldhoen M., Murphy T.L., Murphy K.M., O'Garra A. Interleukin-10 production by Th1 cells requires interleukin-12-induced STAT4 transcription factor and ERK MAP kinase activation by high antigen dose. Immunity 2009, 31:209-219.
27. Saraiva M., O'Garra A. The regulation of IL-10 production by immune cells. Nat. Rev. Immunol. 2010, 10:170-181.
28. Siegel A.M., Herskowitz J.H., Speck S.H. The MHV68 M2 protein drives IL-10 dependent B cell proliferation and differentiation. PLoS Pathog. 2008, 4:e1000039.
29. Sutherland C.L., Heath A.W., Pelech S.L., Young P.R., Gold M.R. Differential activation of the ERK, JNK, and p38 mitogen-activated protein kinases by CD40 and the B cell antigen receptor. J. Immunol. 1996, 157:3381-3390.
30. Vitale G., Mion F., Pucillo C. Regulatory B cells: evidence, developmental origin and population diversity. Mol. Immunol. 2010, 48:1-8.
31. Yanaba K., Bouaziz J.D., Haas K.M., Poe J.C., Fujimoto M., Tedder T.F. A regulatory B cell subset with a unique CD1dhiCD5+ phenotype controls T cell-dependent inflammatory responses. Immunity 2008, 28:639-650.
32. Yanaba K., Bouaziz J.D., Matsushita T., Tsubata T., Tedder T.F. The development and function of regulatory B cells expressing IL-10 (B10 cells) requires antigen receptor diversity and TLR signals. J. Immunol. 2009, 182:7459-7472.
33. Yang M., Sun L., Wang S., Ko K.H., Xu H., Zheng B.J., Cao X., Lu L. Novel function of B cell-activating factor in the induction of IL-10-producing regulatory B cells. J. Immunol. 2010, 184:3321-3325.
34. Yi A.K., Yoon J.G., Yeo S.J., Hong S.C., English B.K., Krieg A.M. Role of mitogen-activated protein kinases in CpG DNA-mediated IL-10 and IL-12 production: central role of extracellular signal-regulated kinase in the negative feedback loop of the CpG DNA-mediated Th1 response. J. Immunol. 2002, 168:4711-4720.
35. Yu R., Mandlekar S., Lei W., Fahl W.E., Tan T.H., Kong A.N. p38 mitogen-activated protein kinase negatively regulates the induction of phase II drug-metabolizing enzymes that detoxify carcinogens. J. Biol. Chem. 2000, 275:2322-2327.